tert-Butyl 3-benzyl-4-oxopiperidine-1-carboxylate

Catalog No. :
ACMTBJ894
CAS No. :
193274-82-7
Molecular Formula :
C17H23NO3
Molecular Weight :
289.38

IUPAC Name:tert-butyl 3-benzyl-4-oxopiperidine-1-carboxylate

tert-Butyl 3-benzyl-4-oxopiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$148.00Login to see priceIn stockIn stock
10g98%$262.00Login to see priceIn stockInquiry
25g98%$531.00Login to see priceIn stockIn stock
100g98%$2060.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-benzyl-4-oxopiperidine-1-carboxylate
IUPAC Nametert-butyl 3-benzyl-4-oxopiperidine-1-carboxylate
MDL No.MFCD08460960
Molecular FormulaC17H23NO3
Molecular Weight289.38
SMILESO=C(N1CC(CC2=CC=CC=C2)C(CC1)=O)OC(C)(C)C
InChI KeyUXRKAOUQKRGROB-UHFFFAOYSA-N
Synonymtert-Butyl 3-benzyl-4-oxopiperidine-1-carboxylate | 193274-82-7 | 1-Boc-3-Benzyl-piperidin-4-one | MFCD08460960 | tert-butyl3-benzyl-4-oxopiperidine-1-carboxylate | 3-benzyl-4-oxo-piperidine-1-carboxylic acid tert-butyl ester | 1-Boc-3-benzyl-4-piperidone | SCHEMBL4480
CAS No.193274-82-7
PubChem CID44607713

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACMTBJ894 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAMBF604 route compound structure diagram
    --
  4. Then
  5. ACMTBJ894 route product structure diagram
    ACMTBJ894193274-82-7 In Stock
Inquiry

2. ACMTBJ894 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMTBJ894 route product structure diagram
    ACMTBJ894193274-82-7 In Stock
Inquiry

Comments (0)